(BUD) Anheuser Busch Inbev - Overview
Stock: Beer, Spirits, Ready-To-Drink, Non-Alcohol Beverages
| Risk 5d forecast | |
|---|---|
| Volatility | 21.4% |
| Relative Tail Risk | -6.90% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.67 |
| Alpha | 45.64 |
| Character TTM | |
|---|---|
| Beta | 0.193 |
| Beta Downside | 0.061 |
| Drawdowns 3y | |
|---|---|
| Max DD | 31.55% |
| CAGR/Max DD | 0.34 |
EPS (Earnings per Share)
Revenue
Description: BUD Anheuser Busch Inbev January 28, 2026
Anheuser-Busch InBev (NYSE:BUD) is a global brewer that markets, distributes and sells roughly 500 beer brands-including Budweiser, Corona Extra, Stella Artois and Michelob Ultra-across North America, Latin America, Europe, the Middle East, Africa and the Asia-Pacific, while also offering spirits-based ready-to-drink (RTD) and non-alcoholic beverages such as Cutwater and NÜTRL.
In its most recent quarter (Q4 FY 2025), AB InBev generated net revenue of **$63.5 billion**, posted an adjusted EBITDA margin of **18.5 %**, and delivered **$5.2 billion** of free cash flow, despite a **2 % YoY decline in comparable volume** that was partially offset by a **12 % rise in RTD sales**, led by the Cutwater line.
Key macro drivers for the brewer include continued pressure on volume from stagnant disposable income in the United States (beer volume down ~3 % YoY) and a shift toward premium and low-alcohol categories, while emerging-market growth remains modest as inflation erodes purchasing power. The sector’s broader trend of expanding RTD and non-alcoholic offerings is expected to provide a higher-margin growth tail for large brewers.
For a deeper, data-driven assessment of AB InBev’s valuation dynamics, you may find the analytics on ValueRay worth exploring.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 8.51b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -4.81 > 1.0 |
| NWC/Revenue: -13.06% < 20% (prev -13.46%; Δ 0.40% < -1%) |
| CFO/TA 0.08 > 3% & CFO 17.61b > Net Income 8.51b |
| Net Debt (61.39b) to EBITDA (16.47b): 3.73 < 3 |
| Current Ratio: 0.72 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.95b) vs 12m ago -2.61% < -2% |
| Gross Margin: 56.01% > 18% (prev 0.46%; Δ 5554 % > 0.5%) |
| Asset Turnover: 34.94% > 50% (prev 36.21%; Δ -1.27% > 0%) |
| Interest Coverage Ratio: 1.80 > 6 (EBITDA TTM 16.47b / Interest Expense TTM 6.41b) |
Altman Z'' 2.50
| A: -0.04 (Total Current Assets 24.77b - Total Current Liabilities 34.48b) / Total Assets 218.81b |
| B: 0.48 (Retained Earnings 105.66b / Total Assets 218.81b) |
| C: 0.05 (EBIT TTM 11.52b / Avg Total Assets 212.72b) |
| D: 0.82 (Book Value of Equity 107.39b / Total Liabilities 131.52b) |
| Altman-Z'' Score: 2.50 = A |
Beneish M -3.41
| DSRI: 0.78 (Receivables 4.26b/5.50b, Revenue 74.33b/74.81b) |
| GMI: 0.83 (GM 56.01% / 46.43%) |
| AQI: 1.00 (AQ_t 0.78 / AQ_t-1 0.77) |
| SGI: 0.99 (Revenue 74.33b / 74.81b) |
| TATA: -0.04 (NI 8.51b - CFO 17.61b) / TA 218.81b) |
| Beneish M-Score: -3.41 (Cap -4..+1) = AA |
What is the price of BUD shares?
Over the past week, the price has changed by -1.78%, over one month by +14.34%, over three months by +29.79% and over the past year by +52.02%.
Is BUD a buy, sell or hold?
- StrongBuy: 5
- Buy: 5
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the BUD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 86.8 | 10.2% |
| Analysts Target Price | 86.8 | 10.2% |
BUD Fundamental Data Overview February 18, 2026
P/E Forward = 19.084
P/S = 2.5969
P/B = 1.7648
P/EG = 1.9334
Revenue TTM = 74.33b USD
EBIT TTM = 11.52b USD
EBITDA TTM = 16.47b USD
Long Term Debt = 70.35b USD (from longTermDebt, last quarter)
Short Term Debt = 14.0m USD (from shortTermDebt, last quarter)
Debt = 70.37b USD (Calculated: Short Term 14.0m + Long Term 70.35b)
Net Debt = 61.39b USD (from netDebt column, last quarter)
Enterprise Value = 212.47b USD (154.05b + Debt 70.37b - CCE 11.94b)
Interest Coverage Ratio = 1.80 (Ebit TTM 11.52b / Interest Expense TTM 6.41b)
EV/FCF = 162.1x (Enterprise Value 212.47b / FCF TTM 1.31b)
FCF Yield = 0.62% (FCF TTM 1.31b / Enterprise Value 212.47b)
FCF Margin = 1.76% (FCF TTM 1.31b / Revenue TTM 74.33b)
Net Margin = 11.46% (Net Income TTM 8.51b / Revenue TTM 74.33b)
Gross Margin = 56.01% ((Revenue TTM 74.33b - Cost of Revenue TTM 32.70b) / Revenue TTM)
Gross Margin QoQ = 55.37% (prev 56.41%)
Tobins Q-Ratio = 0.97 (Enterprise Value 212.47b / Total Assets 218.81b)
Interest Expense / Debt = 1.21% (Interest Expense 848.0m / Debt 70.37b)
Taxrate = 23.24% (720.0m / 3.10b)
NOPAT = 8.84b (EBIT 11.52b * (1 - 23.24%))
Current Ratio = 0.72 (Total Current Assets 24.77b / Total Current Liabilities 34.48b)
Debt / Equity = 0.81 (Debt 70.37b / totalStockholderEquity, last quarter 87.29b)
Debt / EBITDA = 3.73 (Net Debt 61.39b / EBITDA 16.47b)
Debt / FCF = 46.85 (Net Debt 61.39b / FCF TTM 1.31b)
Total Stockholder Equity = 87.02b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.00% (Net Income 8.51b / Total Assets 218.81b)
RoE = 9.78% (Net Income TTM 8.51b / Total Stockholder Equity 87.02b)
RoCE = 7.32% (EBIT 11.52b / Capital Employed (Equity 87.02b + L.T.Debt 70.35b))
RoIC = 5.63% (NOPAT 8.84b / Invested Capital 157.12b)
WACC = 4.84% (E(154.05b)/V(224.41b) * Re(6.63%) + D(70.37b)/V(224.41b) * Rd(1.21%) * (1-Tc(0.23)))
Discount Rate = 6.63% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -1.63%
[DCF Debug] Terminal Value 86.31% ; FCFF base≈5.25b ; Y1≈5.24b ; Y5≈5.52b
Fair Price DCF = 60.04 (EV 164.71b - Net Debt 61.39b = Equity 103.32b / Shares 1.72b; r=5.90% [WACC]; 5y FCF grow -0.88% → 2.90% )
EPS Correlation: 66.05 | EPS CAGR: 13.04% | SUE: 0.85 | # QB: 1
Revenue Correlation: -7.80 | Revenue CAGR: 4.40% | SUE: -0.02 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.94 | Chg30d=N/A | Revisions Net=+0 | Analysts=2
EPS current Year (2026-12-31): EPS=4.32 | Chg30d=+0.155 | Revisions Net=+2 | Growth EPS=+15.8% | Growth Revenue=+6.8%
EPS next Year (2027-12-31): EPS=4.93 | Chg30d=+0.176 | Revisions Net=+2 | Growth EPS=+14.1% | Growth Revenue=+3.8%